Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III randomized double-blind placebo-controlled study of JMKX000189 tablets for induction and maintenance treatment in moderately to severely active ulcerative colitis
CTR20231620Phase 3Completed
- Sponsor
- Shanghai Jiyu Medical Technology
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of JMKX000189 in autoimmune colitis, sponsored by Shanghai Jiyu Medical Technology. Started Sep 2023; status: completed.
02
Drugs
JMKX000189
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20231620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231620.